Insulin-Like Growth Factor 2 mRNA Binding Protein 3 Expression Is an Independent Prognostic Factor in Pediatric Pilocytic and Pilomyxoid Astrocytoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Insulin-Like Growth Factor 2 mRNA Binding Protein 3 Expression Is an Independent Prognostic Factor in Pediatric Pilocytic and Pilomyxoid Astrocytoma
Authors
Keywords
-
Journal
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
Volume 72, Issue 5, Pages 442-449
Publisher
Oxford University Press (OUP)
Online
2013-04-12
DOI
10.1097/nen.0b013e31829023dd
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology
- (2012) A. K. Gnekow et al. NEURO-ONCOLOGY
- Regulation of IMP3 by EGFR signaling and repression by ERβ: implications for triple-negative breast cancer
- (2012) S Samanta et al. ONCOGENE
- Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma
- (2011) Genevieve Schindler et al. ACTA NEUROPATHOLOGICA
- Pathologic Characteristics of Pediatric Intracranial Pilocytic Astrocytomas and Their Impact on Outcome in 3 Countries
- (2011) Tarik Tihan et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Cell cycle and aging, morphogenesis, and response to stimuli genes are individualized biomarkers of glioblastoma progression and survival
- (2011) Nicola VL Serão et al. BMC Medical Genomics
- Insulin Growth Factor-2 Binding Protein 3 (IGF2BP3) Is a Glioblastoma-specific Marker That Activates Phosphatidylinositol 3-Kinase/Mitogen-activated Protein Kinase (PI3K/MAPK) Pathways by Modulating IGF-2
- (2011) Ramaswamy Suvasini et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phase I/II Trial and Pharmacokinetic Study of Cixutumumab in Pediatric Patients With Refractory Solid Tumors and Ewing Sarcoma: A Report From the Children's Oncology Group
- (2011) Suman Malempati et al. JOURNAL OF CLINICAL ONCOLOGY
- Proliferative and metabolic markers in incompletely excised pediatric pilocytic astrocytomas--an assessment of 3 new variables in predicting clinical outcome
- (2011) L. R. Margraf et al. NEURO-ONCOLOGY
- Anaplasia in Pilocytic Astrocytoma Predicts Aggressive Behavior
- (2010) Fausto J. Rodriguez et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival
- (2010) David F Schaeffer et al. BMC CANCER
- Pharmacokinetically Guided Phase 1 Trial of the IGF-1 Receptor Antagonist RG1507 in Children with Recurrent or Refractory Solid Tumors
- (2010) R. Bagatell et al. CLINICAL CANCER RESEARCH
- Histopathologic predictors of pilocytic astrocytoma event-free survival
- (2009) Kathleen M. Tibbetts et al. ACTA NEUROPATHOLOGICA
- The Oncofetal Protein IMP3
- (2009) Wenxin Zheng et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- IMP3 Is a Novel Prognostic Marker that Correlates with Colon Cancer Progression and Pathogenesis
- (2009) Dawei Li et al. ANNALS OF SURGICAL ONCOLOGY
- Duplication of 7q34 in Pediatric Low-Grade Astrocytomas Detected by High-Density Single-Nucleotide Polymorphism-Based Genotype Arrays Results in a NovelBRAFFusion Gene
- (2009) Angela J. Sievert et al. BRAIN PATHOLOGY
- Impact of Morphology, MIB-1, p53 andMGMTon Outcome in Pilocytic Astrocytomas
- (2009) Craig Horbinski et al. BRAIN PATHOLOGY
- IMP3 expression in non–small cell lung cancer
- (2009) Guido Bellezza et al. HUMAN PATHOLOGY
- IMP3 expression in lesions of the biliary tract: a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomas
- (2009) Marc-Oliver Riener et al. HUMAN PATHOLOGY
- Biological effects induced by insulin-like growth factor binding protein 3 (IGFBP-3) in malignant melanoma
- (2009) Geir Frode Ãy et al. INTERNATIONAL JOURNAL OF CANCER
- Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas
- (2009) Tim Forshew et al. JOURNAL OF PATHOLOGY
- IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype
- (2009) Martin Köbel et al. MODERN PATHOLOGY
- Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma
- (2009) D T W Jones et al. ONCOGENE
- External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma
- (2008) Nathan E. Hoffmann et al. CANCER
- BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas
- (2008) Stefan Pfister et al. JOURNAL OF CLINICAL INVESTIGATION
- Gene Expression Profiling of NF-1-Associated and Sporadic Pilocytic Astrocytoma Identifies Aldehyde Dehydrogenase 1 Family Member L1 (ALDH1L1) as an Underexpressed Candidate Biomarker in Aggressive Subtypes
- (2008) Fausto J. Rodriguez et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started